Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C

BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.

Saved in:
Bibliographic Details
Main Authors: Alaa Awad Taha, Ahmad El-Ray, Maged El-Ghannam, Bahaa Mounir
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2010/717845
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567046577061888
author Alaa Awad Taha
Ahmad El-Ray
Maged El-Ghannam
Bahaa Mounir
author_facet Alaa Awad Taha
Ahmad El-Ray
Maged El-Ghannam
Bahaa Mounir
author_sort Alaa Awad Taha
collection DOAJ
description BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.
format Article
id doaj-art-a10c333b365347b8b0323477a96c134a
institution Kabale University
issn 0835-7900
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-a10c333b365347b8b0323477a96c134a2025-02-03T01:02:33ZengWileyCanadian Journal of Gastroenterology0835-79002010-01-01241059760210.1155/2010/717845Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis CAlaa Awad Taha0Ahmad El-Ray1Maged El-Ghannam2Bahaa Mounir3Department of Hepatogastroenterology, Theodor Bilharz Research Institute, EgyptDepartment of Hepatogastroenterology, Theodor Bilharz Research Institute, EgyptDepartment of Hepatogastroenterology, Theodor Bilharz Research Institute, EgyptPathology Department, Faculty of Medicine, Cairo University, Cairo, EgyptBACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.http://dx.doi.org/10.1155/2010/717845
spellingShingle Alaa Awad Taha
Ahmad El-Ray
Maged El-Ghannam
Bahaa Mounir
Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
Canadian Journal of Gastroenterology
title Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
title_full Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
title_fullStr Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
title_full_unstemmed Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
title_short Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C
title_sort efficacy and safety of a novel pegylated interferon alpha 2a in egyptian patients with genotype 4 chronic hepatitis c
url http://dx.doi.org/10.1155/2010/717845
work_keys_str_mv AT alaaawadtaha efficacyandsafetyofanovelpegylatedinterferonalpha2ainegyptianpatientswithgenotype4chronichepatitisc
AT ahmadelray efficacyandsafetyofanovelpegylatedinterferonalpha2ainegyptianpatientswithgenotype4chronichepatitisc
AT magedelghannam efficacyandsafetyofanovelpegylatedinterferonalpha2ainegyptianpatientswithgenotype4chronichepatitisc
AT bahaamounir efficacyandsafetyofanovelpegylatedinterferonalpha2ainegyptianpatientswithgenotype4chronichepatitisc